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Background: Emerging data have suggested that cell surface GRP78 is a multifunctional receptor and has been
linked to proliferative and antiapoptotic signaling cascades. Activated α2−macroglobin (α2M*) is a natural circulating
ligand of cell surface GRP78. Association of cell surface GRP78 with α2M* is involved in the regulation of cell
proliferation, survival and apoptosis in human cancers.
Methods: The invasion and metastasis of HCC cells were examined using transwell and wound healing assay; Cell
surface expression of GRP78 was detected by in cell western assay. Translocation of GRP78 from cytosol to cell surface
was observed by transfection of GRP78-EGFP plus TRIRC-WGA staining. The levels of Src, phosphor-Src, FAK,
phospho-FAK, EGFR, phospho-EGFR, phospho-Cortactin, phospho-Paxillin were determined by western blot. Cell
surface expression of GRP78 in HCC tissue samples was observed by immunofluorescence. The distribution of
Paxillin and Cortactin in HCC cells was also observed by immunofluorescence. The interaction between GRP78
and Src were detected by far-western blot, co-immunoprecipitation and GST pulldown. GRP78 mRNA was
detected by RT-PCR.
Results: In the current study, we showed that association of cell surface GRP78 with α2M* stimulated the invasion and
metastasis of HCC. Cell surface GRP78 could interact directly with c-Src, promoted the phosphorylation of c-Src at Y416.
Inhibition of the tyrosine kinase activity of c-Src with PP2 reverted the stimulatory effect caused by association of cell
surface GRP78 with α2M*. Moreover, association of cell surface GRP78 with α2M* facilitates the interaction between
EGFR and c-Src and consequently phosphorylated EGFR at Y1101 and Y845, promoting the invasion and metastasis of
HCCs. However, inhibition of the tyrosine kinase of c-Src do not affect the interaction between EGFR and Src.
Conclusion: c-Src plays a critical role in the invasion and metastasis of HCC induced by association of cell surface
GRP78 with α2M*. Cell surface GRP78 directly binds and phosphorylates c-Src. As a consequence, c-Src phosphorylated
EGFR, promoting the invasion and metastasis of HCCs.
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Hepatocellular carcinoma (HCC) is the third leading
cause of cancer-related death worldwide [1]. Invasion
and metastasis contributed largely to the high mortality
of HCC [2]. Therefore, exploring the mechanisms regu-
lating the invasion and metastasis is critical for searching
new strategies to improve the outcome of HCC.
Human ɑ2-macroglobulin (α2M) is a typical member
of the pan-proteinase inhibitors of the α2M family,
which is mainly synthesized by the liver [3]. Many data
have reported that α2M is overexpressed in HCC with
the background of hepatitis B infection and the increased
serological α2M is associated with HCC in humans, identi-
fying α2M as a cytochemical marker for the diagnosis of
HCC [4]. α2M is activated by intracellular proteinases.
When activated, α2M binds directly with corresponding
cell surface receptors and functions as a regulator of many
signaling pathways and plays a growth factor-like role in
many human cancers. So far, two cell surface receptors
that specifically bind with activated α2M (α2M*) have
been identified, namely cell surface glucose-regulated pro-
tein 78 (GRP78) and LDL receptor related protein (LRP)
[5]. Upon most occasions, GRP78 is regarded as an endo-
plasmic reticulum chaperone, whose major function is to
fold and process the unfolded or malfolded proteins [6].
However, it is also presented on the cell surface under
stress condition [7]. Cell surface GRP78 acts as a multi-
functional receptor which plays critical role in the pro-
liferation, viability and apoptosis [8, 9]. For example,
association of cell-surface GRP78 with α2M* triggers
MAPK and Akt signaling cascades, promoting cellular
proliferation of 1-LN prostate cancer cells [3, 10, 11].
Ligation of cell surface GRP78 with α2M* activates the
NF-kappaB signaling pathway, decreases p53 level and
plays a stimulatory role in the proliferation and viability
of prostate cancer cells [11, 12].
Although a large body of evidence has linked cell sur-
face GRP78 to proliferative and antiapoptotic signaling
cascades, little is known about the role of cell surface
GRP78 in the invasion and metastasis of human cancer
cells. Cellular Src (c-Src), a non–receptor protein tyro-
sine kinase, is overexpressed and hyperactivated in
many human cancers [13, 14]. Increasing evidence has
demonstrated that c-Src is implicated in the regulation
of a variety of cellular functions, such as tumor inva-
sion and metastasis, by interacting with and phosphor-
ylating a wide range of intracellular proteins including
epithelial growth factor receptor (EGFR) [15]. EGFR is
a member of the ErbB family of receptor tyrosine ki-
nases and is overexpressed in many types of human
cancers including HCC [16]. Accumulating evidence
has suggested that Src could form a complex and me-
diated EGFR phosphorylation, regulating the tumor
progression [17].In this article, we found that GRP78 is overexpressed
on the cell surface in HCC tissue samples. Association
of cell surface GRP78 with α2M* promotes the invasion
and metastasis of HCC in hepatocellular carcinoma cell
lines QGY-7703 and PLC by stimulating the transloca-
tion of GRP78 from the cytosol to plasma. Downstream,
cell surface GRP78 interacts directly with c-Src and pro-
motes the phosphorylation of c-Src at Y416. Moreover,
association of cell surface GRP78 with α2M* facillitates
the interaction between EGFR and c-Src. As a conse-
quence, c-Src phosphorylated EGFR at Y1101 and Y845,
promoting the invasion and metastasis of HCCs.
Methods
Antibodies and other reagents
The following antibodies were used: anti-Src, anti-
pSrcY416, anti-FAKpY397, anti-pPaxillin Y118, anti-
Paxillin, anti-pCortactin Y486, anti-pCortactin Y466,
anti-Cortactin were all from life technologies; anti-
GRP78 N20, antiGRP78 C20 (for antibody blocking),
anti-β-actin were from Santa Cruz. Anti-GRP78 (for
immunoprecipitation and in cell western analysis), anti-
pEGFR Y1101, anti-pEGFR Y1068, anti-pEGFR Y845, anti-
EGFR, anti-p-Tyr and rabbit isotype IgG were obtained
from Abcam. Anti-EGFP was obtained from Origen. All
the secondary antibodies except for IRDYE680RD-
conjugated antibody (LI-COR) were all from abcam. α2M
was purchased from Sigma-Aldrich and activated as pre-
viously reported [18]. PP2, lipofectamine 2000, TRITC-
WGA and fibronectin were from life technologies. Protein
A/G agarose beads and G-sepharose beads were pur-
chased from GE healthcare. RT-PCR kit was from Takara.
Plasma protein isolation kit was purchased from Pierce.
GRP78-EGFP recombinant and corresponding pEGFP-N1
were kindly given by the Cell Biology Department of
China Medical University.
Cell culture and treatment
Human hepatocellular carcinoma cell line QGY-7703
and PLC were purchased from the Type Culture Collec-
tion of Chinese Academy of Sciences (Shanghai, China).
Cells were maintained in DMEM supplemented with 10 %
fetal bovine serum, 1 mM L-glutamine and 1 % penicillin/
streptomycin antibiotics. For experimental purpose, cells
were serum starved for 4 h. PP2 (10 μM for 30 min) or
blocking antibodies (4 μg/ml for 1 h) were added for 1 h,
following α2M* stimulation (50pM for 30 min), cells were
harvested and subjected to subsequent analysis.
Human tissue specimens and ethics statement
All 10 cases of paired HCC tissue samples were obtained
from the Department of Gastroenterology of the General
Hospital of Chinese Liberation Army. The Ethics Commit-
tee of Liaoning Medical College approved and supervised
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experimental performances related to the tissue samples
were in compliance with Helsinki Declaration. We have
got the permissions of all the patients before specimen
collection. The differentiation extents were re-evaluated
by two pathologists according to Edmondson-Steiner
grading system. None of the patients has received chemo-
therapy or irradiation before surgery.Transwell, wound healing assay
In vitro cell invasion and migration were analyzed using
transwell assay and wound healing assay as previously
described [19]. The experiments were repeated for 3
times and the data were represented as X  SD.In cell western assay
In cell western were carried out as previously reported
[10]. Briefly, confluent cells were harvested, diluted to
4 × 105 cells/mL with complete culture medium and dis-
pensed to 96-well culture plate (100 μl per well). After
24 h, cells were rinsed for three times with cold PBS and
serum starved for 4 h. following α2M* stimulation
(50pM for 30 min). Cells were fixed with 2 % formalde-
hyde in PBS, washed for three times with PBS with or
without 0.05 % Tween 20, blocked with 3 % BSA for 2 h
with gentle agitation. After blocking, cells were incu-
bated with anti-GRP78 (1:50 dilution) in blocking solu-
tion overnight with gentle agitation, stained with IRDYE
800 D-conjugated secondary antibody in PBS for 60 min
at RT and washed for three times with PBS and imaged
by LICOOR Odyssey®. Cell surface GRP78 were quanti-
fied according to the manufacturer’s instructions.Western blot
For all western blot experiments, established protocols
were performed [20], using antibodies that recognize
phosphorylated or unphosphorylated EGFR, FAK, c-Src,
Cortactin, Paxllin, β-actin.Cell adhesion assay
The binding ability of tumor cells with fibronectin was
detected using cell adhesion assay. Briefly, pretreated
cells (104 each well) were trypsinized, re-plated on
fibronectin-coated coverslips (10 μg/ml) and incubated
at 37 °C for 1 h. Following incubation, non-adherent
cells were removed by washing for 3 times with PBS,
adherent cells were fixed with 4 % paraformaldehyde
solution, stained with crystal violet (1 %) and dissolved
by 1 % SDS. Absorbances at 595 nm were determined
using a microplate reader.Transfection and plasma staining
Cells were cultured in a six-well culture plate and grown
to 90 % confluent. Before transfection, Cells were cul-
tured in complete medium without antibiotics overnight
and transfected with 4 μg GRP78-EGFP or pEGFP-N1
for 16 μl lipofectamine 2000 in 500 μl Opti-MEM
(Gibco). After 48 h, cells were serum starved for 4 h,
simulated with α2M* for 30 min stained with TRITC
conjugated WGA (1:200 dilution) for 1 h under normal
culture condition. Following WGA staining, cells were
observed using inverted fluorescence microscope (DMI-
4000B, Leica, Germany).
Immunofluorescence
The cellular distribution of Cortactin, Paxillin and
GRP78 was observed using immunofluorescence [21,
22]. Immunofluorescence was performed as previously
reported and observed using laser confocal microscope
(SP5II, Leica, Germany).
Cell surface protein biotinylation
Confluence cells were rinsed with ice-cold PBS twice
and serum starved for 4 h. PP2 was added for 30 min.
following α2M* stimulation, EZ-link Sulfo-NHS-LC-Biotin
(Pierce, USA) was added to cover the surface of the cell
layer and the flasks were gently shaken at 4 °C for 30 min.
The biotinylation reaction was stopped by adding Tris–
HCl (pH 7.5) to a final concentration to 100 nM. Then,
the cells were rinsed with ice-cold PBS twice and then
lysed with RIPA buffer and Neutravidin-agarose beads
(Pierce, USA) were added in whole cell lysate overnight
and incubated at 4 °C with agitation. The beads were
washed for 5 times with PBS buffer. The cell surface pro-
teins were released by 1× SDS-PAGE sample loading
buffer and heating at 100 °C for 5 min. The cell surface
proteins were subjected to western blotting analysis.
RT-PCR
Conventional RT-PCR was performed as previously
reported [23].
Far-western blot assay
Far-western blot was performed as previously reported
[24]. Cell surface proteins (50 μg each lane) were resolved
by 10 % SDS-PAGE, transferred onto PVDF membranes
(Millipore, USA). The membranes were incubated at room
temperature for 2 h in 50 mM Tris–HCl (pH 7.4),
150 mM NaCl, 0.1 % (v/v) Tween 20, 0.5 % (w/v) bovine
serum albumin (TBST/BSA) and then overnight at 4 °C
on a shaker with the biotin-conjugated recombinant
human GRP78(rhGRP78) (5 μg in 1 ml TBST/BSA).
The membranes were washed for 3 times with TBST,
incubated for 4 h with anti-biotin antibody (1:1000
dilution). Following incubation with primary antibody,
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with appropriate AP-conjugated secondary antibody
(1:5000 dilution). The membrane were stained with
BCIP/NBT solution and photographed with a bioima-
ging system (I-BOX, UVP, USA).
Co-immunoprecipitation assay
One thousand micrograms of plasma membrane protein
extract from each sample was pre-cleared with 50 μl of
protein A/G-Sepharose beads for 1 h at 4 °C and incu-
bated with 5 μg of anti-GRP78 or anti-EGFR (Abcam)
overnight at 4 °C on a rotator. Following antibody incu-
bation, 50 μl of protein A/G-Sepharose beads (50 %
slurry) were added and rotated at 4 °C for 3 h. The beads
were then centrifuged at 12,000 g for 5 min and washed
for 5 times with the lysis buffer. The precipitates were
eluted by adding of 20 μl of 1× SDS-PAGE sample load-
ing buffer (50 mm Tris–HCl, pH 6.8, 100 mm DTT, 2 %
SDS, 0.1 % bromphenol blue, 10 % glycerol), followed by
heating at 100 °C for 5 min. The supernatant obtained
after centrifugation was resolved by SDS-PAGE and sub-
jected to Western blot analysis.
GST pulldown assay
Plasma membrane extract was isolated as described previ-
ously. The clarified plasma membrane extract was incu-
bated with 50 μl of a 50 % slurry of glutathione-Sepharose
4B (GE Healthcare, USA) and 25 μg GST for 1 h at 4 °C.
GST-Grp78-bound resin, GST-bound resin was incubated
with cell lysates containing 1 mg protein extract overnight
at 4 °C on a rotator. The resin was then washed 5 times
with ice-cold lysis buffer. Proteins were eluted by adding
25 μl of 2 × Laemmli sample buffer at 100 °C for 5 min
and centrifuged for 5 min at 12,000 g. The supernatant
was resolved by SDS-PAGE and subjected to Western blot
analysis using anti-c-Src (Abcam).
Statistical analysis
Comparison of the data was performed using one way
ANOVA, student t-test and chi-square test. A p-value less
than 0.05 was considered to be statistically significant.
Results
Association of cell surface GRP78 with α2M* facilitated
the invasion and metastasis of HCC
Increasing data have linked α2M* to pro-proliferative
and anti-apoptotic role. However, whether it plays a role
in the invasiveness and metastasis of HCC remains un-
known. To investigate the role of α2M* in tumor inva-
sion, QGY-7703 and PLC cells were serum starved for
4 h, followed by stimulation with α2M* for 30 min (50
pM) [10]. Using transwell assay, we found that treatment
of QGY-7703 and PLC cells with α2M* caused signifi-
cant increase in the invasiveness relative to that in cellstreated with vehicle, indicating that α2M* stimulation fa-
cilitates the invasion of QGY-7703 (Fig. 1a) and PLC
cells (Fig. 1b). We next assessed whether α2M* modulate
the metastasis of cancer cells using wound healing assay
and found that stimulation with α2M* significantly facili-
tated the metastasis of QGY-7703 (Fig. 1c) and PLC cells
(Fig. 1d).
To investigate whether cell surface GRP78 is the surro-
gate of α2M* in this process, serum starved QGY-7703
and PLC cells were pretreated with the antibody directed
against the NH2-termnial domain (NTD), COOH-
terminal domain (CTD) of GRP78 or isotype IgG for 1 h
followed by α2M* stimulation [25, 26]. Transwell assay
revealed that pretreatment with the GRP78 NTD antibody
caused a marked decrease in the invasion potential as
compared with vehicle upon α2M* stimulation. However,
pretreatment with CTD had no effect on the invasion
potential as compared with pretreatment with isotype IgG
or vehicle upon α2M* stimulation (Fig. 1e-g). Using cell
adhesion assay, we found that blockade of cell surface
GRP78 with the NTD antibody decreased the binding
ability of tumor cells to fibronectin in QGY-7703 cells
(Fig. 1h). These data suggested that cell surface is the
surrogate of α2M* and cell surface GRP78 promotes the
invasion and metastasis by its NH2-terminal domain.
α2M* induced GRP78 translocation from cytosol to cell
surface in HCC
We next determined whether α2M* affected the cell sur-
face expression of GRP78 in QGY-7703 and PLC cells.
Serum starved QGY-7703 and PLC cells were treated
with α2M* and vehicle. Using in cell western assay, cell
surface and total GRP78 were determined with or with-
out Tween 20 permeabilization. We found that α2M*
stimulation significantly elevated the cell surface faction
of GRP78, whereas did not affect total GRP78 in
QGY-7703 and PLC cells (Fig. 2a). In QGY-7703 cells,
α2M* stimulation caused a ~2.7 fold increase in the cell
surface expression of GRP78 as compared with vehicle.
In PLC cells, a ~2.1 fold increase was observed upon
α2M* stimulation (Fig. 2b). Using RT-PCR, we found
that GRP78 mRNA levels in cells treated with α2M*
were similar with that in QGY-7703 and PLC cells
treated with vehicle (Fig. 2c). These data suggested that
the elevated expression of cell surface GRP78 is not regu-
lated at transcriptional and translational level and raised
the possibility that α2M* could induce the translocation of
GRP78 from cytosol to plasma membrane. To answer this
question, we transiently transfected GRP78-EGFP into
QGY-7703 cells [27]. After 48 h of transfection, exogenous
and endogenous GRP78 were examined using western
blot (Fig. 2d). QGY-7703 cells transfected with GRP78-
EGFP were serum starved for 4 h, followed by α2M*
stimulation, stained with TRITC-conjugated wheat germ
Fig. 1 (See legend on next page.)
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Fig. 1 Association of cell surface GRP78 with α2M* facilitated the invasion and metastasis of HCC. (a-b) Transwell analysis of the invasion of serum
starved QGY-7703 and PLC cells treated with vehicle and α2M*. (c-d) Wound healing analysis of the migration of serum starved QGY-7703 and PLC
cells treated with vehicle and α2M*. (e) Transwell analysis of the effect of antibody blocking on the invasion of serum starved QGY-7703 and PLC cells
treated with vehicle and α2M*. (f-g) Quantitative analysis of the effect of antibody blocking on the invasion of serum starved QGY-7703 and PLC cells
treated with vehicle and α2M*. (h) Cell adhesion analysis of the effect of antibody blocking on the binding ability to fibronectin in QGY-7703 cells. All
these experiments were repeated for 3 times in triplicate. These data were presented as X  SD and analyzed using student’s t-test and one-way
ANOVA. The difference is regarded to be statistically significant when p < 0.05. *represented that the difference is statistically significant
Fig. 2 α2M* induced GRP78 translocation from cytosol to cell surface in HCC. (a) In cell western analysis of cell surface GRP78 and total GRP78 in
serum starved QGY-7703 and PLC cells treated with vehicle or α2M*. (b) Schematic show of cell surface GRP78 expression in serum starved QGY-7703
and PLC cells treated with vehicle or α2M*. The experiments were repeated for 3 times in triplicate. The data were presented as X  SD and analyzed
using student’s t-test. The difference is regarded to be statistically significant when p < 0.05. * represented that the difference is statistically significant.
(c) RT-PCR analysis of GRP78 mRNA levels in serum starved QGY-7703 and PLC cells treated with vehicle or α2M*. (d), Western blot analysis of exogenous
and endogenous GRP78 in serum starved QGY-7703 cells transfected with GRP78-EGFP or pEGFP-N1. (e) Confocal microscopy observation of GRP78
translocation from cytosol to cell surface in serum starved QGY-7703 cells with or without α2M* stimulation. Scale Bar 25 μm
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Zhao et al. BMC Cancer  (2015) 15:389 Page 7 of 14agglutinin (TRITC-WGA), a specific plasma membrane
dye. Using confocal microscopy, we found that GRP78
colocalized with TRITC-WGA on the cell surface (yellow
on the cell surface) in α2M* treated cells. By contrast, the
colocalization of GRP78 and TRITC-WGA was not ob-
served in cells treated with vehicle (Fig. 2e). These data
demonstrated that α2M* induces the translocation of
GRP78 from cytosol to cell surface.
c-Src interacts directly with GRP78 on the cell surface
of HCCs
We have previously reported that cell surface GRP78 fa-
cilitates the invasion of HCC [28]. To further extend this
finding, we sought to determine the downstream target
of cell surface GRP78. For this purpose, we compared
tyrosine-phosphorylated proteins in serum starved QGY-
7703 cells treated with α2M* or vehicle. As determined
by western blot using anti-p-Tyr antibody. A tyrosine
phosphorylated band migrating at ~60 KDa was signifi-
cantly induced in QGY-7703 cells treated with α2M*,
suggesting that cell surface GRP78 may regulate the
phosphorylation of a unknown tyrosine kinase whoseFig. 3 c-Src interacts directly with GRP78 on the cell surface of HCCs. (a) W
starved QGY-7703 cells treated with vehicle or α2M*. (b) Far western blot a
starved QGY-7703 cells and PLC cells using biotin conjugated rhGRP78 as b
GRP78 and c-Src in the plasma membrane extracts from serum starved QG
SDS-PAGE; bottom, western blot. (d) GST pulldown analysis of the interacti
serum starved QGY-7703 cells using GST-GRP78 as the bait. Upper, SDS-PAGmolecular weight is ~60 KDa (Fig. 3a). Based on this re-
sult, we tried to determine whether cell surface GRP78
regulated the activity of c-Src in HCCs. We first identi-
fied GRP78 binding proteins in the whole cell lysates
from QGY-7703 and PLC cells by far-western blotting
using the biotin-conjugated rhGRP78 as the bait. For
this purpose, we isolated plasma membrane proteins
using cell surface protein biotinylation assay and per-
formed co-immunoprecipitation experiment using the
anti-GRP78 antibody (Abcam). As shown in Fig. 3b, a
protein, migrating at ~60 kDa, could interact specifically
with the biotin-conjugated rhGRP78. Moreover, we sub-
jected the precipitated proteins to SDS-PAGE and found
a ~60 kDa band in the precipitated proteins. Western
blotting showed that c-Src is presented in the proteins
co-precipitated with GRP78, suggesting that the cell sur-
face GRP78 modulates the activity of Src by direct inter-
action (Fig. 3c). Finally, we performed GST-pulldown
assay to verify the interaction between cell surface
GRP78 and c-Src using GST-GRP78 as the bait. We
found that a ~60 kDa band by SDS-PAGE and identified
that this protein was c-Src by western blot (Fig. 3d).estern blot analysis of the tyrosine-phosphorylated proteins in serum
nalysis of GRP78 binding proteins in the whole cell lysates from serum
ait. (c) Co-immunoprecipitation analysis of the interaction between
Y-7703 cells using anti-GRP78 (Abcam) as precipitating antibody. Upper,
on between GRP78 and c-Src in the plasma membrane extracts from
E; bottom, western blot
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c-Src and its downstream signaling pathways
Using western blot, we examined p-Src phosphorylation
at Y416 in cell lysates from serum starved QGY-7703
and PLC cells treated with α2M* or vehicle. We found
that α2M* stimulation significantly increased p-c-Src
levels as compared with vehicle in both QGY-7703 and
PLC cells, indicating that cell surface GRP78 facilitates
c-Src phosphorylation in HCC (Fig. 4a). We next deter-
mined whether the tyrosine kinase activity of c-Src is in-
volved in the regulation of adhesion and invasion of HCC
cells in QGY-7703 cells. Serum starved QGY-7703 cells
were pretreated with PP2 at a concentration of 10 μM for
30 min followed by α2M* stimulation. Cell adhesion assay
revealed that pretreatment of serum starved QGY-7703
cells with PP2 caused a significant decrease in binding
ability to fibronectin as compared with vehicle upon α2M*
stimulation. No difference was observed between cells
treated with PP2 alone and cells treated with PP2 followed
by α2M* stimulation (Fig. 4b). The invasion potentials
were analyzed using transwell assay. As shown in Fig. 4c,
pretreatment of serum starved QGY-7703 cells with PP2Fig. 4 Association of Cell surface GRP78 with α2M* activates c-Src and its dow
levels of c-Src and pY416-Src in serum starved QGY-7703 and PLC cells treate
pretreatment on the binding ability of serum starved QGY-7703 cells to fibron
pretreatment on the invasion of serum starved QGY-7703 cells upon α2M* sti
the binding ability of serum starved PLC cells to fibronectin upon α2M* s
the invasion of serum starved PLC cells upon α2M* stimulation. (f) Weste
signaling pathways in serum starved QGY-7703 and PLC cells treated with
blocking on the phosphorylation levels of c-Src at Y416 and FAK at Y397
repeated for 3 times in triplicate. The data were presented as X  SD and an
significant when p < 0.05. *represented that the difference is statistically signifcaused a marked decrease in the invasion potential as
compared with vehicle upon α2M* stimulation. It is worth
to note that QGY-7703 cells treated with PP2 alone share
similar inhibitory extent on tumor invasion as compared
with cells pretreated with PP2 followed by α2M* stimula-
tion. Similar results were obtained in PLC cells (Fig. 4d-e).
These data suggested that c-Src is the downstream signal-
ing molecule of α2M*. We also examined whether cell
surface GRP78 could activate c-Src downstream signaling
pathways [29]. As shown in Fig. 4f, treatment of serum
starved QGY-7703 and PLC cells with α2M* caused sig-
nificant increase in the phosphorylation levels of FAK
(Y397), Cortactin (Y486 and 466) and Paxillin (Y118) as
compared with vehicle treated cells.
Although many data have demonstrated that α2M*
could bind with cell surface GRP78 and stimulate the
signaling pathways downstream of cell surface expression
of GRP78, we still need to preclude the possibility that
α2M* binds with other cell surface protein and facilitates
c-Src phosphorylation. To obtain this goal, serum starved
QGY-7703 and PLC cells were incubated with the anti-
body directed against the NH2-termnial domain (NTD)nstream signaling pathways. (a) Western blot analysis of the expression
d with vehicle and α2M*. (b) Cell adhesion analysis of the effect of PP2
ectin upon α2M* stimulation. (c) Transwell analysis of the effect of PP2
mulation. (d) Cell adhesion analysis of the effect of PP2 pretreatment on
timulation. (e) Transwell analysis of the effect of PP2 pretreatment on
rn blot analysis of the phosphorylation status of c-Src downstream
vehicle and α2M* (g) Western blot analysis of the effect of antibody
in serum starved QGY-7703 and PLC cells. These experiments were
alyzed using student’s t-test. The difference is regarded to be statistically
icant
Fig. 5 Association of Cell surface GRP78 with α2M* induces invadopodia formation. QGY-7703 cells were treated with vehicle, α2M*, PP2 or PP2
in combination with α2M* and co-stained with TRITC-conjugated Phalloidin and anti-Cortactin antibody. The distribution of F-actin (red) and
cortactin (green) was observed using a confocal microscope. The invadopodia was indicated as yellow patches. Scale Bar 25 μm
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to α2M* stimulation. Many reports by other groups have
demonstrated that the antibodies we used could block the
binding of cell surface GRP78 with α2M*. Western blot
analysis showed significantly lower pY416-Src and pY397-
FAK levels in cells pretreated with NTD antibody as com-
pared with cells pretreated with isotype IgG upon α2M*
stimulation. However, pretreatment with CTD antibody
did not affect pY416-Src and pY397-FAK levels (Fig. 4g).
These data suggested that cell surface GRP78 is the surro-
gate of α2M* induced c-Src phosphorylation and activates
c-Src via its NH2-terminal domain.
Association of cell surface GRP78 with α2M* induces
invadopodia formation and Paxillin redistribution
Invadopodia is a specialized invasive organelle for tumor
cells undergoing invasion and metastasis [30]. To investi-
gate whether cell surface GRP78 regulates the formationFig. 6 Association of Cell surface GRP78 with α2M* induces paxillin format
combination with α2M* and stained with anti-Paxillin antibody. The distrib
Bar 25 μmof invadopodia, the distribution of Cortactin in serum
starved QGY-7703 cells treated with α2M* or vehicle was
observed using immunofluorescence [21]. By co-staining
of Cortactin and F-actin, we observed that treatment with
α2M* caused a marked increase in the number of speckles
in cell cortex as compared with that treated with vehicle,
while pretreatment with PP2 significantly decreased the
number of speckles on cell cortex. Furthermore, α2M*
stimulation caused a subtle increase the number of speckles
in cell cortex in PP2 pretreated cells, indicating that c-Src is
essential for the formation of invadopodia induced by asso-
ciation of cell surface GRP78 with α2M* (Fig. 5).
We also observed whether association of cell surface
GRP78 with α2M* could cause the redistribution of
Paxillin. Immunofluorescence microscopy revealed that
Paxillin exhibited a dense punctate distribution on the
cell periphery in serum starved QGY-7703 cells treated
with α2M*as compared with that treated with vehicle,ion. QGY-7703 cells were treated with vehicle, α2M*, PP2 or PP2 in
ution Paxillin (green) was observed using a confocal microscope. Scale
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bution of Paxillin. Pretreatment with PP2 decreased the
cell periphery distribution. Moreover, α2M* stimulation
caused a moderate increase in the cell periphery distri-
bution of Paxillin in PP2 pretreated cells, indicating the
critical role of c-Src in Paxillin redistribution caused by
association of cell surface GRP78 with α2M* (Fig. 6).
Association of cell surface GRP78 with α2M* facillitated
the maximal activation of EGFR in a c-Src dependent
manner
For the critical role of EGFR in the invasion and metasta-
sis of HCC, we wonder whether cell surface GRP78 could
regulate EGFR phosphorylation. For this purpose, we
examined EGFR phosphorylation levels at Y1068, Y845
and Y1101 in serum starved QGY-7703 cells treated with
α2M* or vehicle. Using western blot, we found that α2M*
stimulation significantly increased the phosphorylation
level of EGFR at Y1068, Y845 and Y1101 as compared
with vehicle, while did not affect EGFR expression. Pre-
treatment of serum starved QGY-7703 cells with PP2
caused a marked decrease in the phosphorylation of EGFR
at Y845 and Y1101 as compared with cells pretreatment
with vehicle upon α2M* stimulation. However, PP2
treatment did not affected EGFR phosphorylation at
Y1068 (Fig. 7a, b).Fig. 7 Association of Cell surface GRP78 with α2M* facilitated the maximal ac
of the expression and phosphorylation of EGFR in serum starved QGY-7703 tr
Quantitative analysis of the expression and phosphorylation of EGFR in serum
with α2M*. (c) Co-immunoprecipitation analysis of the interaction between c
α2M*, PP2 or PP2 in combination with α2M*. (d) Quantitative analysis of the i
treated with vehicle, α2M*, PP2 or PP2 in combination with α2M*Accumulating evidence has shown that EGFR is a
downstream signaling molecule of c-Src and c-Src could
directly bind with EGFR and activate EGFR [31, 32, 17].
We next determined whether cell surface GRP78 could
regulate the interaction between EGFR and c-Src. For
this purpose, whole cell lysates from serum starved
QGY-7703 cells treated with α2M* or vehicle were
immuonprecipitated with excessive anti-EGFR antibody
(~5 μg in a 1 ml volume containing 1 mg of total protein).
The precipitations were subjected to western blot analysis
and we found that c-Src level in the whole cell lysate from
α2M* treated cells was higher than that from vehicle
treated cells. It is worth to note that c-Src was not de-
tected in isotope IgG precipitation. These data indicated
that cell surface GRP78 facilitates the interaction between
EGFR and c-Src (Fig. 7c). These data raised the question
whether the tyrosine kinase activity of c-Src is essential for
the interaction between EGFR and c-Src induced by cell
surface GRP78. Using Co-immuoprecipitation in the lysates
from serum starved QGY-7703 cells pretreated with PP2 or
vehicle prior to α2M* stimulation, we found that the
amount of c-Src co-immunoprecipitated with EGFR in the
whole cell lysate from PP2 pretreated cells were paralleled
with that from cells pretreated with vehicle, indicating that
the tyrosine kinase activity of c-Src is not essential for the
interaction between EGFR and c-Src (Fig. 7c, d).tivation of EGFR in a c-Src dependent manner. (a) Western blot analysis
eated with vehicle, α2M*, PP2 or PP2 in combination with α2M*. (b)
starved QGY-7703 treated with vehicle, α2M*, PP2 or PP2 in combination
-Src and EGFR in serum starved QGY-7703 cells treated with vehicle,
nteraction between c-Src and EGFR in serum starved QGY-7703 cells
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samples of HCC
Using immunofluorescence, we observed the cellular
localization of GRP78 in ten cases of paired surgically
resected HCC tissue samples. We found that GRP78 is
expressed both in the cytosol and on the cell surface in
9 of 10 cases HCC tissue samples (Fig. 8c, d). By contrast,
cell surface staining of GRP78 was not observed (7 of 10
cases) or very weak (3 of 10 cases) of paired peri-cancer
tissue samples (Fig. 8a, b). Statistical chi-square test
revealed that the difference is significant (p < 0.01). These
data demonstrated that GRP78 is highly expressed on the
cell surface of HCC.
Discussion
Cell surface GRP78 has been implicated in the progression
of many human cancers including melanoma, breast,
prostate cancer and hepatocellular carcinoma [9]. Lots of
data have linked cell surface GRP78 to pro-proliferative
and anti-apoptotic signaling pathway [33]. However, the
role of cell surface GRP78 in tumor invasion and me-
tastasis remains poor documented. In this article, weFig. 8 Cell surface GRP78 expression in tissue samples of HCC. Immunofluore
GRP78 is localized on the cell surface in HCC tissue samples (b) and (d). On th
paired peri-cancer tissue samples. Scale Bar 25 μmstimulated hepatocellular carcinoma cell lines PLC and
QGY-7703 with α2M* and demonstrated that c-Src is
the surrogate in cell surface GRP78 induced tumor inva-
sion and metastasis. Cell surface GRP78 facilitated the
phosphorylation of c-Src at Y416 via direct interaction.
Although many data have identified α2M* as a natural
ligand of cell surface GRP78, the mechanism by which
α2M* activates cell surface GRP78 remains unclear.
Here, we found that α2M* did not augment GRP78 ex-
pression at transcriptional and translational levels. Based
on these results, we hypothesized that elevated presence
of GRP78 on the cell surface may be caused by GRP78
redistribution. In consistent with our hypothesis, we
demonstrated that α2M* could induce GRP78 transloca-
tion from cytosol to plasma. Furthermore, we demon-
strated that cell surface GRP78 is the surrogate of α2M*
induced invasion and metastasis in HCC. It is the NH2-
terminal domain of GRP78 but not the COOH-terminal
domain played critical role in tumor invasion and metas-
tasis. Other reports have demonstrated the critical roles
of COOH-terminal domain of GRP78 in the regulation
of proliferation and apoptosis in many types of humanscence analysis of GRP78 expression in 10 cases paired HCC samples.
e contrary, it is not expressed (c) or expressed at very low level (a) in
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[3, 10, 34]. For example, ligation of cell surface GRP78
with α2M* promotes the proliferation of cancer cells in
prostate cancer cells, blockade of cell surface GRP78
using the antibody against the COOH-terminal domain
of GRP78 reverted the pro-proliferative effect of α2M*
[10, 11, 35, 36]. Taken together, these data suggested that
cell surface GRP78 regulated the invasion, metastasis, pro-
liferation and apoptosis with different mechanism. That is
the NH2-terminal domain of GRP78 is involved in the
regulation of tumor invasion and metastasis. However, the
COOH-terminal domain of GRP78 is involved in the
regulation of proliferation and apoptosis of tumor cells.
Further investigation of potential downstream molecules
of cell surface GRP78 revealed that cell surface GRP78
could interact directly with a ~60KDa protein and aug-
ment its phosphorylation in QGY-7703 and PLC cells.
Furthermore, we identified the ~60KDa protein as c-Src.
These raised the question of how cell surface GRP78 and
c-Src interaction affected the invasion and metastasis of
HCC. To answer this question, we analyzed whether pre-
treatment with PP2 could inhibit α2M* induced adhesion
and invasion in QGY-7703 cells. We found that inhibition
of the tyrosine kinase activity of c-Src inhibited α2M*
induced adhesion and invasion. The inhibitory extents
were paralleled in cells treated with PP2 with or without
α2M* stimulation. We further found that blockade of cell
surface GRP78 using the antibody against the NH2 ter-
minal domain of GRP78 inhibited the phosphorylation of
Src at Y416 and FAK at Y397. However, the antibody
against the COOH terminal domain of GRP78 did not
affect Src and FAK phosphorylation. These data further
demonstrated that the NH2-domain of cell surface GRP78
is involved in the regulation of tumor invasion and metas-
tasis upon α2M* stimulation. Conflicting results have been
described regarding the role of the NH2-terminal domain
of GRP78 in the regulation of cell proliferation and apop-
tosis. In NCCIT cells, blockade of Cripto binding to cell
surface GRP78 using the antibody against the NH2-
terminal domain inhibited tumor cell proliferation, sug-
gesting that the NH2-terminal domain of cell surface
GRP78 also plays a pro-proliferative role in NCCIT cells
[26]. This could be explained by the difference in ligands
that bind with GRP78 [37, 38]. This opinion was supported
by the fact that binding of cell surface GRP78 with Par-4
played an pro-apoptotic role in prostate cancer [25, 39].
We also found that ligation of cell surface GRP78 with
α2M* triggered EGFR signaling pathway in a Src-dependent
manner. Inhibition of the tyrosine kinase activity inhibited
EGFR phosphorylation at Y1101 and Y845 induced by
α2M* stimulation. However, treatment of PP2 did not in-
hibit the phosphorylation at Y1068, indicating that Src plays
critical role in the maximal activation of EGFR in HCC.
This raised the question of how c-Src may regulate EGFRactivity induced by the association of cell surface GRP78
with α2M*. Other reports have demonstrated that Src
could regulate EGFR activity by direct interaction. We
found that association of cell surface GRP78 with α2M* fa-
cilitated the interaction between c-Src and EGFR. Further-
more, inhibition of the tyrosine kinase did not affect the
interaction between c-Src and EGFR. However, inhibition
of Src tyrosine kinase activity inhibiting the maximal activa-
tion of EGFR by preventing the phosphorylation of EGFR
at Y845 and Y1101. These data were consistent with the role
of c-Src in EGFR activation and suggested that both tyrosine
kinase activity and protein binding function of Src are
essential for cell surface GRP78 induced EGFR activation.
Conclusion
Our research revealed that c-Src plays a critical role in
the invasion and metastasis of HCC induced by associ-
ation of cell surface GRP78 with α2M*. Cell surface
GRP78 directly binds and phosphorylates c-Src. As a
consequence, c-Src phosphorylated EGFR, promoting
the invasion and metastasis of HCCs.
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